Denmark· DK-28106455720
Zanosar
A streptozocin product containing streptozocin, registered in Denmark by Orifarm A/S. The same ATC class is registered in 9 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Streptozocin is registered in 9 of 19 countries.
Countries holding a registration under ATC L01AD04 (streptozocin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 5 of them publish a price we can compare per daily dose
Streptozocin · ATC L01AD04
9 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Streptozocin
- Manufacturer
- Orifarm A/S
- Country
- Denmark (DK)
- ATC code
- L01AD04
- ATC class
- Streptozocin
- Defined daily dose
- 96 mg, P
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106455720
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
151 interactions on record for streptozocin.
Graded by severity as the source publishes them — 40 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Streptozocin · interactions on record
151 records
- 40 severe
- 97 moderate
- 14 minor
Most severe, free to view
- Nalidixic acidJ01MB02severe
- CidofovirJ05AB12severe
- ThiotepaL01AC01severe
- CladribineL01BB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01AD04
Streptozocin, as other registers publish it.
- BelgiumStreptozocine Esteve 1 gEsteve Pharmaceuticals
- FinlandZanosarOrifarm Oy
- United StatesZanosarESTEVE PHARMACEUTICALS, S.A.
- United StatesZanosarESTEVE PHARMACEUTICALS, S.A.
- DenmarkZanosarEsteve Pharmaceuticals S.A.S.
- GermanyZanosarEsteve Pharmaceuticals S.A.S.
- United StatesZanosarESTEVE PHARMACEUTICALS, S.A.
- NorwayZanosarESTEVE PHARMACEUTICALS S.A.S.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd16681a-1a4e-498f-ac74-f2cfbf256bbc GET /v1/drugs/fd16681a-1a4e-498f-ac74-f2cfbf256bbc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "pulver til koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "1 g",
"auth_role": "DKMA",
"dk_drugid": "28106455720",
"substance": "Streptozocin",
"auth_procedure": "Par-Imp",
"in_medicinpriser": true,
"registration_date_serial": "44000"
}See everything about streptozocin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.